G&E Herbal Biotechnology Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Kou-Wha Kou

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

G&E Herbal Biotechnology (GTSM:4911) Is In A Strong Position To Grow Its Business

Apr 20

G&E Herbal Biotechnology (GTSM:4911) Is In A Strong Position To Grow Its Business

Jan 08

Geschäftsführer

Kou-Wha Kou

no data

Amtszeit

Mr. Kou-Wha Kou, Ph D., is CEO & Chairman of G&E Herbal Biotechnology Co. Ltd.

G&E Herbal Biotechnology Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

G&E Herbal Biotechnology Co., Ltd., Annual General Meeting, Jun 21, 2024

Recent updates

New minor risk - Market cap size

Second quarter 2024 earnings released: EPS: NT$0.42 (vs NT$0.30 in 2Q 2023)

Upcoming dividend of NT$0.57 per share

New minor risk - Market cap size

Now 20% undervalued after recent price drop

Now 18% undervalued

Now 20% undervalued

Now 20% undervalued

Now 20% undervalued after recent price drop

First quarter 2024 earnings released: EPS: NT$0.35 (vs NT$0.27 in 1Q 2023)

Full year 2023 earnings released: EPS: NT$1.30 (vs NT$0.13 in FY 2022)

G&E Herbal Biotechnology Co., Ltd., Annual General Meeting, Jun 21, 2024

New minor risk - Market cap size

Second quarter 2023 earnings released: EPS: NT$0.30 (vs NT$0.052 loss in 2Q 2022)

Full year 2022 earnings released: EPS: NT$0.13 (vs NT$0.36 loss in FY 2021)

Third quarter 2022 earnings released: EPS: NT$0.10 (vs NT$0.055 loss in 3Q 2021)

Second quarter 2022 earnings released: NT$0.05 loss per share (vs NT$0.083 loss in 2Q 2021)

First quarter 2022 earnings released: NT$0.09 loss per share (vs NT$0.06 loss in 1Q 2021)

Third quarter 2021 earnings released: NT$0.06 loss per share (vs NT$0.06 loss in 3Q 2020)

Second quarter 2021 earnings released: NT$0.08 loss per share (vs NT$0.092 loss in 2Q 2020)

First quarter 2021 earnings released: NT$0.06 loss per share (vs NT$0.071 loss in 1Q 2020)

G&E Herbal Biotechnology (GTSM:4911) Is In A Strong Position To Grow Its Business

Full year 2020 earnings released: NT$0.26 loss per share (vs NT$0.42 loss in FY 2019)

New 90-day low: NT$29.70

New 90-day low: NT$30.10

G&E Herbal Biotechnology (GTSM:4911) Is In A Strong Position To Grow Its Business

New 90-day low: NT$33.85

New 90-day low: NT$34.50

New 90-day low: NT$36.00

Third quarter 2020 earnings released: NT$0.06 loss per share

First half earnings released

Geschäftsführer

Amtszeit